These findings indicate that the addition of atezolizumab or durvalumab to platinum-doublet chemotherapy improves the ORR and ...
The FDA has approved a new subcutaneous (SC) formulation of pembrolizumab (Keytruda Qlex), co-formulated with ...
Silent lung diseases develop without symptoms and many people are unaware of the changes to their lungs. Its early symptoms are easily confused with minor maladies, causing delays in diagnosis. Early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback